One-pot protocol for the synthesis of quinoxalines from styrenes, o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine using triiodoisocyanuric acid
Substituted quinoxalines were obtained in good to excellent yields with wide substrate scope and functional-group tolerance.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Triiodoisocyanuric acid (TICA) controlled one-pot and easy-operational protocol has been developed for the synthesis of substituted phenylquinoxalines (3a-3i) and phenyl-[1,2,5]thiadiazolo[3,4-f]quinoxaline (5a5f) from styrenes with o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine respectively.
📊
Temel Bulgular & Veri:The reaction involves co-bromination and oxidation for the formation of an a-bromo ketone as an intermediate in the presence of triiodoisocyanuric acid, followed by condensation with the o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine for the formation of phenylquinoxalines (3a-3i) and phenyl- [1,2,5]thiadiazolo[3,4-f]quinoxaline (5a-5f) in 55-79% yield.
💡
Sonuç & Katkı:Substituted quinoxalines were obtained in good to excellent yields with wide substrate scope and functional-group tolerance.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Triiodoisocyanuric acid (TICA) controlled one-pot and easy-operational protocol has been developed for the synthesis of substituted phenylquinoxalines (3a-3i) and phenyl-[1,2,5]thiadiazolo[3,4-f]quinoxaline (5a5f) from styrenes with o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine respectively. The reaction involves co-bromination and oxidation for the formation of an a-bromo ketone as an intermediate in the presence of triiodoisocyanuric acid, followed by condensation with the o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine for the formation of phenylquinoxalines (3a-3i) and phenyl- [1,2,5]thiadiazolo[3,4-f]quinoxaline (5a-5f) in 55-79% yield. This protocol environmentally benign and economically viable. Substituted quinoxalines were obtained in good to excellent yields with wide substrate scope and functional-group tolerance.
🔖
Bu Makaleye Atıf Yap
BOWROJU, S. K., MARUMAMULA, H., BAVANTHULA, R. (2021). One-pot protocol for the synthesis of quinoxalines from styrenes, o-phenylenediamine and benzo[c][1,2,5]thiadiazole-4,5-diamine using triiodoisocyanuric acid. Organic Communications, Cilt: 14 - Sayı: 1, 48–57. https://ajindex.com/articles/288443
Antoniotti, S.; Dunach, E. Direct and catalytic synthesis of quinoxaline derivatives from epoxides and ene-1,2- diamines. Tetrahedron Lett. 2002, 43, 3971–3973.
Guillon, J.; Grellier, P.; Labaied, M.; Sonnet, P.;Leger, J.M.; Deprez-Poulain, R.; Forfar- Bares, I.; Dallemagne, P.; Lemaitre, N.; Pehourcq, F.; Rochette, J.; Sergheraert, C.; Jarry, C. Synthesis, Antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, vispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines. J. Med. Chem. 2004, 47,1997–2009.
Alleca, S.; Corona, P.; Loriga, M.; Paglietti, G.; Loddo, R.; Mascia, V.; Busonera, B.; La C. Quinoxaline chemistry. Part 16. 4-Substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N- [4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity. Farmaco 2003, 58, 639–650.
Desplat, V.; Geneste, A.; Begorre, M.-A.; Fabre, S. B.; Brajot, S.; Massip, S.; Thiolat, D.; Mossalayi, D.; Jarry, C.; Guillon, J. Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of akt kinase. J. Enzyme Inhib. Med. Chem. 2008, 23, 648–658.
Desplat, V.; Moreau, S.; Gay, A.; Fabre, S. B.; Thiolat, D.; Massip, S.; Macky, G.; Godde, F.; Mossalayi, D.; Jarry, C.; Guillon, J. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2- a]quinoxaline derivatives, potential inhibitors of akt kinase. Part II. J. Enzyme Inhib. Med. Chem. 2010, 25, 204–215.
Guillon, J.; Forfar, I.; Mamani-Matsuda, M.; Desplat, V.; SaliHge, M.; Thiolat, D.; Massip, S.; Tabourier, A.; Liger, J.-M.; Dufaure, B.; Haumont, G.;Jarry, C.; Mossalayi, D. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Bioorg. Med. Chem. 2007, 15, 194–210.
Gemma, S.; Colombo, L.; Forloni, G.; Savini, L.; Fracasso, C.; Caccia, S.; Salmona, M.; Brindisi, M.; Joshi, B. P.; Tripaldi, P.; Giorgi, G.; Taglialatela-Scafati, O.; Novellino, E.; Fiorini, I.; Campiani, G.; Butini, S. Pyrroloquinoxalinehydrazones as fluorescent probes for amyloid fibrils. Org. Biomol. Chem. 2011, 9, 5137– 5148. Antoniotti, S.; Donach, E. Direct and catalytic synthesis of quinoxaline derivatives from epoxides and ene1,2-diamines. Tetrahedron Lett. 2002, 43, 3971-3973.
Raw, S.A.; Wilfred, C.D.; Taylor R.J.K. Tandem oxidation processes for the preparation o